Company Directories & Business Directories
REPARE FIBRE
Company Name: Corporate Name:
REPARE FIBRE
Company Title:
Company Description:
Keywords to Search:
Company Address:
105 Rue Daoust #B,SAINT-EUSTACHE,QC,Canada
ZIP Code: Postal Code:
J7R6P4
Telephone Number:
4504730952
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):
449304
USA SIC Description:
Boat Repairing
Number of Employees:
1 to 4
Sales Amount:
Less than $500,000
Credit History:
Credit Report:
Very Good
Contact Person:
Andre Levesque
Remove my name
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example , Blogger Example )
copy to clipboard
Company News:
Repare Therapeutics | Synthetic Lethality Precision Oncology Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines
Repare | Synthetic Lethality Precision Oncology | About Repare Therapeutics is a leading clinical-stage precision oncology company enabled by our proprietary synthetic lethality approach to discovering and developing novel therapeutics We developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair
Repare Therapeutics | Precision Oncology | Investor Relations Corporate Profile for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines
Repare | Synthetic Lethality Precision Oncology | Pipeline Check out the drug pipeline for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing synthetic lethal therapies
Repare | Synthetic Lethality Precision Oncology | Leadership Learn about the team at Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines
Repare Therapeutics | Synthetic Lethality | Press Releases Press releases for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines
Repare | Synthetic Lethal Therapies | Discovery Platform Learn about scientifc discovery platorm at Repare Therapeutics, a clinical-stage precision oncology company developing novel, synthetic lethal medicines
Repare Therapeutics | Precision Oncology | Repare Therapeutics Doses . . . Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics
Repare Therapeutics | Synthetic Lethality | Polϴ Inhibitor Repare is developing a small molecule inhibitor of polymerase theta, or Polθ, a SL target associated with BRCA mutations and other genomic alterations
Repare Therapeutics | RP-6306 PKMYTI Inhibitor Repare's RP-6306 is a first-in-class small molecule being developed as a selective PKMYT1 inhibitor that preferentially kills tumor cells overexpressing CCNE1